Manufacturing Anti-CD19 CAR-Tscm Cells for Immunotherapy Using Innovative Microbubble-Based Technologies for Precision Cell Processing

CD19 体内 细胞疗法 嵌合抗原受体 细胞毒性T细胞 免疫疗法 CD8型 单元格排序 癌症研究 微气泡 过继性细胞移植 化学 免疫学 抗原 体外 医学 细胞 流式细胞术 生物 免疫系统 生物化学 生物技术 超声波 放射科
作者
Chuntang Fu,Guixin Shi,Yu‐Tsueng Liu
出处
期刊:Blood [Elsevier BV]
卷期号:138 (Supplement 1): 3889-3889 被引量:2
标识
DOI:10.1182/blood-2021-144684
摘要

Abstract INTRODUCTION Chimeric antigen receptor (CAR) T cell therapy provides a potential cure for patients who don't respond to standard treatments. One of the major challenges for current mainstream CAR-T therapy is lack of in vivo persistence of transferred cells. Intriguingly, more differentiated effector T cells that acquire enhanced in vitro anti-tumor properties were found to be paradoxically less effective for in vivo tumor treatment. It has become clear that the persistence of adoptive transferred T cells is crucial for in vivo activities. A significant linear correlation was found between the differentiation status of infused T cells and the potency of tumor regression, in the order of Tscm > Tcm >Tem. While promising, CAR-Tscm cell therapy demands technical innovation for precision cell processing and production. Here, we show CAR-Tscm cells generated by microbubble-based technologies for precision T cell sorting and activation and viral transduction are more robust than those generated by the conventional method in in vitro assays and in vivo animal study using the NSG mouse model. METHODS Naïve T cells were isolated by sequential sorting with 3 targeted lipid shell microbubbles (conjugated with anti-CD8, anti-CD45RA, and anti-CD62L). Briefly, CD8+ T cells were floated by anti-CD8 conjugated microbubbles and separated from nontargeted cells in PBMC. The floated CD8+ cells returned to solution after the microbubbles had undergone dissolution by increasing ambient pressure. These cells were subsequently floated by anti-CD45RA and anti-CD62L microbubbles sequentially, as described earlier. To generate CD19-CAR-modified Tscm-enriched cells, isolated naïve T cells were activated by anti-CD3/CD28 conjugated microbubbles and transduced by CD19-CAR retrovirus via Retronectin conjugated microbubbles. Transduced naïve T cells were cultured in media with IL-7, IL-21, and TWS119. Control CD19-CAR T cells were produced from same donors' PBMCs using standard culture conditions (soluble IL-2 and anti-CD3/CD28 coated culture flasks). Raji cells were co-cultured with effector cells (Tscm-enriched and standard CD19 CAR T cells) at a gradient ET ratio for in vitro cytotoxicity assay. Tscm-enriched and standard CD19-CAR T cells were injected into Raji-luc-bearing NSG mice. Tumor burden was measured by the XenogenIVIS system. RESULTS Naïve CD8+ T lymphocytes were enriched by sequential isolation of CD8+, CD62L+, and CD45RA+ cells from healthy donor PBMCs using respective antibody conjugated microbubbles. The CD8, CD62L, and CD45RA triple positive population was enriched from initial 10.08%± 2.4% to 71.84%±1.9% (n=4). We discovered that Retronectin conjugated microbubbles are advantageous to replace spinoculation technique to simplify viral transduction procedures. The average transduction efficiency was 27.71%± 8.7% using unconcentrated retroviral vectors. The Tscm-like cells were significantly enriched after two-week culture, compared to the standard method (37.78± 14.5% vs. 4.38± 0.7%). Tscm-enriched CD19-CAR T cells exhibited a stronger in vitro cytotoxicity towards Raji cells in comparison with standard CD19-CAR T cells (Figure 1). Consistently, in the NSG mice engrafted with Raji-Luc cancer cells, the CD19-CAR-modified Tscm-enriched cells showed longer-lasting antitumor responses than the CD19-CAR-T cells generated by the standard manufacturing process (Figure 2). CONCLUSION We have developed a bead-free, multi-positive selection system for CAR-Tscm production, and demonstrated that these Tscm cells effectively cause tumor regression and prolong diseased animal lifespan. A closed, automated, microbubble-based CAR-T cell manufacturing system, combining T cell isolation, activation, and transduction will be developed to improve performance and reduce costs. Figure 1 Figure 1. Disclosures Fu: Diagnologix LLC: Current Employment. Shi: Diagnologix LLC: Current Employment. Liu: Diagnologix LLC: Current Employment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
田南松发布了新的文献求助10
4秒前
搬砖美少女完成签到,获得积分10
4秒前
nn发布了新的文献求助10
5秒前
7ohnny完成签到,获得积分10
6秒前
apckkk完成签到 ,获得积分10
8秒前
深情安青应助550190946采纳,获得10
9秒前
10秒前
11秒前
jbq完成签到 ,获得积分20
11秒前
YM完成签到,获得积分10
13秒前
生动柔发布了新的文献求助10
13秒前
大旭完成签到 ,获得积分10
14秒前
Fn完成签到 ,获得积分10
16秒前
zero完成签到,获得积分10
18秒前
瘦瘦谷兰完成签到,获得积分10
18秒前
zcz完成签到 ,获得积分10
19秒前
白嘉乐完成签到,获得积分10
20秒前
考研小白完成签到,获得积分10
20秒前
高妍纯完成签到 ,获得积分10
22秒前
24秒前
风中的丝袜完成签到,获得积分10
24秒前
赵赵完成签到,获得积分10
27秒前
27秒前
shiizii应助科研通管家采纳,获得10
28秒前
xuzj应助科研通管家采纳,获得10
28秒前
Mars应助科研通管家采纳,获得30
28秒前
Hello应助科研通管家采纳,获得10
28秒前
叶梓轩完成签到 ,获得积分10
28秒前
上官若男应助科研通管家采纳,获得10
28秒前
28秒前
28秒前
机智的锦程完成签到 ,获得积分10
29秒前
时尚俊驰发布了新的文献求助10
31秒前
华仔完成签到,获得积分10
31秒前
甜甜友容完成签到,获得积分10
35秒前
程哲瀚完成签到,获得积分10
35秒前
35秒前
副本完成签到 ,获得积分10
35秒前
淡然画笔完成签到,获得积分10
36秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022